HITGEN
HitGen is provides biological reagents and services to support drug discovery research.
HITGEN
Industry:
Biotechnology Health Care Medical
Founded:
2012-01-01
Address:
Chengdu, Sichuan, China
Country:
China
Website Url:
http://www.hitgen.com
Total Employee:
251+
Status:
Active
Contact:
+86 28 85197385
Email Addresses:
[email protected]
Total Funding:
39.07 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Euro Microsoft Azure DNS ASP.NET IIS Google Analytics Classic
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-12 | Vernalis | Vernalis acquired by HitGen | 25 M USD |
Investors List
CDH Investments
CDH Investments investment in Series B - HitGen
leadyond capital
leadyond capital investment in Series B - HitGen
Official Site Inspections
http://www.hitgen.com Semrush global rank: 9.37 M Semrush visits lastest month: 168
- Host name: 15.9.63.50.host.secureserver.net
- IP address: 50.63.9.15
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "HitGen"
About HitGen
HitGen Inc. (SSE: 688222.SH), is a drug discovery research company with headquarters in Chengdu, China, and subsidiaries in Cambridge, UK and Houston, USA. ... HitGen won …See details»
About Us - HitGen
HitGen has multiple programmes from early discovery to clinical trial stage. For more information, please call +86-28-85197385, +1-508-840-9646 or visit www.hitgen.com. For media inquiries: …See details»
HitGen - Crunchbase Company Profile & Funding
HitGen may be growing as indicated by its full year 2023 earnings report where it surpassed earnings per share (EPS) expectations. This financial metric suggests that the company has …See details»
HitGen - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... HitGen Inc. (SSE: …See details»
HitGen - Scientist.com
HitGen Inc. is a rapidly developing biotech company headquartered in Chengdu, China, with subsidiaries in Cambridge, UK and Houston, USA. It became a publicly listed company in …See details»
HitGen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
HitGen has also partnered with Pfizer , Boehringer Ingelheim , and Cancer Research UK among others to leverage its high throughput screening capabilities. ... The statistics for drugs in the …See details»
HitGen - Overview, News & Similar companies | ZoomInfo.com
Who is HitGen. HitGen Inc. is a biotech company headquartered in Chengdu, China, with subsidiaries in Cambridge, UK and Houston, USA. It became a publicly listed company in …See details»
HitGen Inc. (SHA: 688222) Company Profile & Overview - Stock …
4 days ago HitGen Inc. operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally. Its technology platform includes DNA-encoded library technology; fragment-based drug discovery and structure-based drug design technologies; emerging technology platforms for synthetic therapeutic oligonucleotide technology; and …See details»
Org Chart HitGen - The Official Board
HitGen has 16 executives and 1 subsidiary. HitGen. Vernalis Research; Please confirm your deletion . Delete or Cancel . Unfortunately, you don't own enough credit to see this new org …See details»
HitGen - Org Chart, Teams, Culture & Jobs - The Org
View HitGen's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
DNA encoded library - HitGen
HitGen has multiple programmes from early discovery to clinical trial stage. For more information, please call +86-28-85197385, +1-508-840-9646 or visit www.hitgen.com. For media inquiries: …See details»
Structural Genomics Consortium and HitGen Announce Research ...
Mar 10, 2023 TORONTO, Canada, October 3, 2023 – The Structural Genomics Consortium (SGC) today announced that it has entered into a partnership with Shanghai Stock Exchange …See details»
HitGen Company Profile - Office Locations, Competitors, Revenue …
HitGen has 5 employees across 2 locations and $39 m in total funding,. See insights on HitGen including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
HitGen Locations - Contract Research Map
HitGen has approximately 20 in-house drug discovery programs at different stages of research & development. HitGen is collaborating with pharmaceutical, biotech and chemical …See details»
About History - HitGen
HitGen won the award of "The Biopharmas with Most Growth Potential" in the selection of "The 12th Reputation List of China Listed Companies in 2022" sponsored by National Business …See details»
HitGen - Contacts, Employees, Board Members, Advisors & Alumni …
Organization. HitGen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Number of Board Member and Advisor Profiles 1. …See details»
HitGen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Dec 1, 2024 The intellectual property of HitGen includes 49 registered patents primarily in the ' Organic Chemistry ' category, according to IPqwery. Additionally, HitGen has registered 7 …See details»
Board of Directors - HitGen
HitGen Pharmaceuticals Inc.(US Subsidiary) Tel : +1-(508)-840-9646 Vernalis (R&D) Limited (UK Subsidiary) Granta Park,Great Abington Cambridge,CB21 6GB United Kingdom Tel : …See details»
Services - HitGen
HitGen offers comprehensive drug discovery services (target validation, hit identification, hit-to-lead, lead optimization, preclinical studies, IND filing and clinical development) centered around our world-leading DNA-encoded compound library (DEL) technologies and Fragment-based drug discovery (FBDD) to our customers.We have flexible business models, including single …See details»
Organization: HitGen - Cbonds.com
HitGen. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»